Hematology-Oncology Clinics of North America

Papers
(The median citation count of Hematology-Oncology Clinics of North America is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Hepatic Perfusion for Diffuse Metastatic Cancer to the Liver140
Copyright72
Forthcoming Issues66
Clinical Characteristics and Treatment of Familial Hemophagocytic Lymphohistiocytosis40
Treatment of High-Risk Gestational Trophoblastic Neoplasia36
Insights into Renal Cell Carcinoma with Novel Imaging Approaches35
The Management of Relapsed or Refractory Waldenström’s Macroglobulinemia35
Autoimmune Hemolytic Anemia: An Old Disease with New Twists35
Conflict and Access to Health Care34
Chimeric Antigen Receptor T-Cells in Indolent Lymphoma, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia33
Managing First-Line Metastatic Renal Cell Carcinoma33
Future Directions for Gestational Trophoblastic Disease33
Benefits and Harms of Interception and Early Detection of Cancer29
Advances in Gastric Cancer Surgical Management27
Racial and Ethnic Disparities in Colorectal Cancer Screening and Outcomes25
The Evolving Landscape of Drug Therapies for Sickle Cell Disease25
Updates in the Management of Warm Autoimmune Hemolytic Anemia25
Hematology/Oncology Clinics of North America24
Contents23
Contributors23
Disparities in Breast Cancer Outcomes and How to Resolve Them22
Contributors22
Copyright21
Factor XIII Deficiency19
Advances in Immunotherapy in Esophagogastric Cancer18
Convergence of Precision Oncology and Liquid Biopsy in Non-Small Cell Lung Cancer18
Contents17
Isocitrate Dehydrogenase Wild-type Glial Tumors, Including Glioblastoma16
Liposarcoma16
Foreword15
Advances in Surgical Techniques for Lung Cancer15
Chimeric Antigen Receptor T Cells in Hodgkin and T-Cell Lymphomas15
The Need for Translational Epidemiology in Beta Thalassemia Syndromes15
Clinical Characteristics and Treatment of Histiocytic Disorders in Children14
Histiocytic Disorders in Pediatric and Adult Patients14
Inherited Platelet Disorders13
Skin Cancer Precursors13
Adult Evans' Syndrome13
Copyright13
Emerging Therapies in β-Thalassemia13
Advances in Systemic Therapy in Pancreatic Cancer13
Genomic Alterations in Langerhans Cell Histiocytosis13
Forthcoming Issues12
Clinical Vignettes Part I12
Red Cell Antigens and Antibodies12
The Evolving Role of Surgery in Multimodal Cancer Care12
Evaluation and Management of Bing–Neel Syndrome12
Genes as Medicine11
Gestational Trophoblastic Neoplasia11
Malignancies of the Upper Gastrointestinal Tract11
Copyright11
Hereditary Renal Cell Carcinoma Syndromes11
The Evolving Role of Neurosurgical Intervention for Central Nervous System Tumors11
Advances in the Surgical Management of Esophageal Cancer10
Local Control in Soft Tissue Sarcomas10
High-Risk Non-Melanoma Skin Cancers10
Patient-Reported Outcomes in Radiation Oncology10
CAR T Cells: Past Successes, Current Limitations, and Future Opportunities9
Evolution of Gene Therapy, Historical Perspective9
Frontline Management of Waldenström Macroglobulinemia with Chemoimmunotherapy9
Heavy Ion Particle Therapy in Modern Day Radiation Oncology9
Contents9
Bispecific Antibodies in the Treatment of Multiple Myeloma8
Contents8
Systemic Therapy for Early- and Late-Stage, Human Epidermal Growth Factor Receptor-2-Positive Breast Cancer8
New Developments in Myeloma8
Melanoma Brain Metastasis8
Radiation-Induced Tissue Regeneration8
Forthcoming Issues8
Isocitrate Dehydrogenase Mutant Grade II and III Glial Neoplasms8
Copyright7
Contents7
Disparities and Inequities Among Patients with Central Nervous System Tumor7
Education and Training Models for Remote Learning7
Breast Cancer and Lifestyle Factors7
Immunobiology and Metabolic Pathways of Renal Cell Carcinoma7
Clinical Complications and Their Management7
Advances in Human Epidermal Growth Factor Receptor 2-Targeted Therapy in Upper Gastrointestinal Cancers7
Copyright7
Breast Cancer in India7
Targeted Therapy Innovations for Melanoma6
Hemophilia A/B6
Impact of Clonal Heterogeneity in Multiple Myeloma6
Ductal Carcinoma In Situ6
Chimeric Antigen Receptor T-Cell Therapy for Solid Tumors6
FLASH Radiotherapy6
Adjuvant and Neoadjuvant Therapy in Renal Cell Carcinoma6
Extraordinary Progress in the Treatment of Multiple Myeloma: Is a Cure on the Horizon?6
Disorders of Fibrinogen and Fibrinolysis6
Advances in the Imaging of Esophageal and Gastroesophageal Junction Malignancies6
Current Status and Future Directions of Gene-Based Therapy for Pediatric Blood Diseases6
Early Detection of Precursor Diseases of Multiple Myeloma6
PARPis and Other Novel, Targeted Therapeutics in Pancreatic Adenocarcinoma5
Clinical Classification, Screening, and Diagnosis in Beta-Thalassemia and Hemoglobin E/Beta-Thalassemia5
Copyright5
Complications of Autoimmune Hemolytic Anemia5
Merkel Cell Carcinoma5
Remembering the Contributions of Professor David J. Weatherall5
Contents5
Sarcomas5
Genetics and Genomics of Gestational Trophoblastic Disease5
Contributors5
Immunotherapy-associated Autoimmune Hemolytic Anemia5
Proteasome Inhibitor-Based Regimens in the Frontline Management of Waldenström Macroglobulinemia5
Contributors5
Forthcoming Issues5
Approach to High-Risk Multiple Myeloma5
Autoimmune Hemolytic Anemia: Diagnosis and Differential Diagnosis5
When Is It Important to Sequence Sarcomas and Other Mesenchymal Neoplasms? A Practical Guide to Molecular Testing5
Pathogenic Mechanisms in Thalassemia I5
Pathogenic Mechanisms in Thalassemia II5
Impact of Prostate Cancer in Eastern Europe and Approaches to Treatment and Policy5
Renal Cell Cancer5
Local Therapies in Advanced Colorectal Cancer5
Placental Site Trophoblastic Tumors and Epithelioid Trophoblastic Tumors5
Immune Effector Cell-associated Hemophagocytic Lymphohistiocytosis-like Syndrome (IEC-HS)5
Immune-Pathogenesis of Myeloma5
Cancer Therapy-induced Dermatotoxicity as a Window to Understanding Skin Immunity4
Waldenström Macroglobulinemia4
Role of Radiation in Treatment of Renal Cell Carcinoma4
Contributors4
Preface4
Emerging Biomarkers of Response to Systemic Therapies in Metastatic Clear Cell Renal Cell Carcinoma4
Functional Radiosurgery in the Management of Cancer Pain4
BTK Inhibitors in the Frontline Management of Waldenström Macroglobulinemia4
Genetics of Familial Hemophagocytic Lymphohistiocytosis (HLH)4
Regulatory Aspects of Gene Therapy4
Cutaneous T-cell Lymphoma4
Gastrointestinal Cancer Precursor Conditions and Their Detection4
Debate4
Escalation, De-escalation, Adaptation, Speciation, Customization: The New Approaches to Breast Cancer4
Chronic Lymphocytic Leukemia4
Role of Immunotherapy in Early- and Late-Stage Triple-Negative Breast Cancer4
Hereditary Colorectal Cancer4
Breast Cancer Pathology in the Era of Genomics4
Contents4
Smoldering Multiple Myeloma4
The Current State of Chimeric Antigen Receptor T Cell Therapy for B Lymphoblastic Leukemia4
Understanding and Managing Infectious Complications in Chronic Lymphocytic Leukemia4
Management of Waldenström Macroglobulinemia in Limited-Resource Settings4
Is There Still a Role for Stem Cell Transplantation in Multiple Myeloma?4
Innovation and Emerging Technologies in Radiation Oncology4
Contents4
Role of Ovarian Suppression in Early Premenopausal Breast Cancer4
Microbiome and Immunotherapy for Melanoma3
Patient, Caregiver, and Provider Well-Being in Oncology3
Contributors3
Contents3
Screening and Surveillance for Pancreatic Adenocarcinoma in High-Risk Individuals3
Emerging Role of Blood-based Biomarkers in Sarcomas3
New Therapies on the Horizon3
Role of Surgery in Metastatic Renal Cell Carcinoma3
Evolving Role of Circulating Tumor DNA and Emerging Targeted Therapy in Colorectal Cancer3
Surgical Management of Genitourinary Cancer Liver Metastases3
Forthcoming Issues3
The Emerging Potential of Lead-212 Theranostics3
Colorectal Cancer in Younger Adults3
Contributors3
Preface3
Copyright3
Contributors3
Evolving Concepts in the Management of Desmoid Tumors3
Advances and Opportunities in the Management of Lung Cancer3
Forthcoming Issues3
Copyright3
Contents3
Forthcoming Issues3
Surgical Management of Neuroendocrine Tumor Liver Metastases3
First-Line Treatment of Driver-Negative Non–Small Cell Lung Cancer3
Biology and Treatment of Meningiomas3
Surgical Management of Gestational Trophoblastic Neoplasia3
Forthcoming Issues3
Contributors3
The Evolving Role for Systemic Therapy in Resectable Non-small Cell Lung Cancer3
Contents3
Impact of Social Media on Oncology Care2
Immunotherapy2
Neurofibromatoses2
Macrophage Activation Syndrome2
Quality of Life in Sickle Cell Disease2
Surgical Management of the Axilla for Breast Cancer2
Fighting Cancer in Ukraine at Times of War2
The Gut Microbiome in Colorectal Cancer2
Managing Metastatic Renal Cell Carcinoma after Progression on Immunotherapy2
Smart Solutions to Address the Global Gap in Radiation Oncology Through Trainee Engagement and Partnerships with Industry2
Locally Advanced Lung Cancer2
Copyright2
Resistance to Bruton Tyrosine Kinase Inhibitors2
Adjuvant Systemic Therapy for Postmenopausal, Hormone Receptor-Positive Early Breast Cancer2
Gene-Based Therapies for Pediatric Blood Diseases2
Copyright2
Hematopoietic Stem Cell Transplantation in Thalassemia2
Artificial Intelligence, Machine Learning and Big Data in Radiation Oncology2
Copyright2
Gene Therapy for Hemoglobinopathies2
Forthcoming Issues2
Sickle Cell Disease: New Approaches for an Old Disease2
Contents2
The Chronic Lymphocytic Leukemia Epigenome2
Systemic Therapy Improvements Will Render Locoregional Treatments Obsolete for Patients with Cancer with Liver Metastases2
Colorectal Cancer: Advancing Science, Improving Access, and Refining Therapy2
Pathology of Gestational Trophoblastic Disease (GTD)2
Surgical Management of Colorectal Cancer Liver Metastases2
Factor XI Deficiency2
Contributors2
Radiotherapy for Pancreatic Adenocarcinoma2
The Role of the Pathologist in Renal Cell Carcinoma Management2
Novel Immune Therapies for Renal Cell Carcinoma2
Economics of Sickle Cell Disease and Evidence to Support Comprehensive Care2
Hemophilia B (Factor IX Deficiency)2
Gene Therapy for Inborn Errors of Immunity2
Lung Cancer2
Novel Targeted Therapies for Renal Cell Carcinoma2
Nonoperative Management for Rectal Cancer2
Decision-Making Regarding Perioperative Therapy in Individuals with Localized Pancreatic Adenocarcinoma2
Cervical Cancer2
Evidence-Based Guidance for Breast Cancer Survivorship2
Contributors1
Hemophagocytic Syndromes1
Biology and Treatment of HER2-Low Breast Cancer1
Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma1
Nonsurgical Therapy for Early-Stage Lung Cancer1
Contributors1
Contributors1
Proteasome Inhibitors in Multiple Myeloma1
External Beam Radiation Therapy for Liver Metastases1
Copyright1
Triplet Therapies in Chronic Lymphocytic Leukemia1
Leptomeningeal Disease1
Contributors1
Autonomous B-cell Receptor Signaling in Chronic Lymphocytic Leukemia1
Contents1
Clinical Vignettes, Part II: Eyes, Teeth, and Bone1
Evaluation and Management of Disease Transformation in Waldenström Macroglobulinemia1
Contributors1
Is There a Role for Locoregional Therapies for Non-colorectal Gastrointestinal Malignancies?1
Emergence of Circulating Tumor DNA as a Precision Biomarker in Lung Cancer Radiation Oncology and Beyond1
Copyright1
Ultra High-risk Gestational Trophoblastic Neoplasia1
Gastrointestinal Stromal Tumor1
Structural Racism and Impact on Sickle Cell Disease1
Cancer Precursor Syndromes and Their Detection in the Head and Neck1
Management of Relapsed and/or Refractory Chronic Lymphocytic Leukemia1
What Is New in Small Cell Lung Cancer1
Is There a Role for Immunotherapy in Central Nervous System Cancers?1
Central Nervous System Complications Among Oncology Patients1
Role of Consolidation and Maintenance1
Contents1
Contents1
The Development of Neuroimaging Biomarkers for Cognitive Decline in Sickle Cell Disease1
0.077830076217651